Today: 10 April 2026
Subscribe

Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex, saved by its workers in 2024, remains financially unstable, with 2025 sales projected below the €35 million break-even point. The glassmaker launched a €5 million public crowdfunding campaign, offering 8% returns, to fund new products and factory upgrades. Director General François Marciano says banks remain cautious until results improve. Employees have cut costs and rotated store shifts to avoid new hires.
21 October 2025
Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics shares rose about 17% to $30 after the FDA granted RMAT and Orphan Drug designations to its lead gene-editing programs, BEAM-101 and BEAM-302. Early trial data showed BEAM-302 raised protective AAT levels and BEAM-101 produced durable increases in fetal hemoglobin. Wall Street’s average 12-month price target is $45–46, implying roughly 70–80% upside.
21 October 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 21.10.2025

Weatherford International reported Q3 earnings of $81 million, or $1.12 per share, missing analyst estimates and down from $157 million a year earlier. Revenue dropped 12.6% to $1.232 billion. U.S. stocks ended mixed as the Dow rose 0.5%, the S&P 500 was flat, and the Nasdaq slipped. General Motors raised its forecast, while Netflix fell after missing targets.
21 October 2025
·
DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo shares rose over 34% in after-hours trading Oct. 20, 2025, after announcing it will acquire telehealth provider SteadyMD using cash on hand. DocGo reported Q2 revenue of $80.4 million, down 51% year-over-year, and a net loss of $13.3 million. The company ended Q2 with $128.7 million in cash. A 2023 securities fraud lawsuit against DocGo remains active.
21 October 2025
·
SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

Spero shares closed at $2.29 on Oct. 20, 2025, up 3.6%, after reporting Phase 3 trial results showing oral tebipenem HBr matched IV imipenem in overall success (58.5% vs 60.2%) at IDWeek. The stock has surged over 120% year-to-date, trading between $0.51 and $3.22. GSK plans an FDA submission in Q4. Analyst 12-month targets average $5, but ratings remain mixed following a recent Zacks downgrade.
21 October 2025
···
Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune shares jumped 99% to $8.94 on Oct. 20, 2025, after the FDA accepted its resubmitted BLA for lead cancer therapy RP1 plus nivolumab, setting a PDUFA decision date for April 10, 2026. New trial data showed a 44% response rate in acral melanoma. The stock’s rebound follows a 73% plunge in July after an FDA rejection. Market cap stands near $698 million.
21 October 2025
·
Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat shares surged 128% to $1.47 on Oct. 20 after a volatile week driven by a short squeeze and heavy trading volumes. The company completed a debt-for-equity swap on Oct. 15, cutting $900 million in debt but diluting shareholders as outstanding shares jumped from 76.7 million to 392 million. Sales and profits continue to fall, and analysts remain broadly bearish.
21 October 2025
·
Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix shares closed at $1,238.56 on Oct. 20, up 3.3% and near all-time highs ahead of Q3 earnings. Analysts expect Q3 revenue of about $11.5 billion and EPS of $6.9–7.0, with focus shifting to advertising and margins. Netflix ended Q2 with 302 million paid subscribers and $2.3 billion in free cash flow. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
21 October 2025
··
Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs shares surged nearly 20% on Oct. 20, closing at $15.50 after Q3 results and rare-earth exploration plans. The company posted Q3 revenue of $4.73 billion and an adjusted loss of $0.45 per share, narrower than expected. Executives credited new U.S. steel tariffs for stronger demand and multi-year auto contracts. The stock is up about 42% year-to-date, far outpacing peers.
21 October 2025
·
Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Crumbl Cookies leased 2,300 square feet at 2717 N. Salisbury Blvd. for its first Eastern Shore Maryland store, set to open November 2025. 7 Brew will open its first Salisbury drive-thru at 1503 S. Salisbury Blvd., with construction starting soon. Crumbl operates over 1,000 locations nationwide. 7 Brew reached 500 U.S. stores by October 2025 amid rapid drive-thru coffee growth.
21 October 2025
White House U-Turn: Student Loan Forgiveness Approved for Millions After Court Deal

White House U-Turn: Student Loan Forgiveness Approved for Millions After Court Deal

The Trump administration agreed on Oct. 17, 2025, to resume canceling federal student debt for 2–2.5 million borrowers in income-driven repayment plans, under a court settlement with the AFT. The Education Department will process loan discharges for those who made 20–25 years of payments. Forgiven debt through 2025 will not trigger federal tax bills. Notices to eligible borrowers began arriving in early October.
21 October 2025
Gold Bonanza 2025: Price Soars Past $4,400 as Diamond District Frenzy Hits New York – Is $5,000 Next?

Gold Bonanza 2025: Price Soars Past $4,400 as Diamond District Frenzy Hits New York – Is $5,000 Next?

Gold hit a record $4,381 per ounce on Oct. 20 and traded near $4,300 on Oct. 21, up about 60–63% in 2025. Central banks and funds have poured $64 billion into gold ETFs this year, with retail sellers and buyers crowding New York’s Diamond District. Silver also reached a 14-year high at $54.5 per ounce. Major banks now forecast gold could reach $5,000 per ounce by 2026.
21 October 2025
···
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Soars to Record High on iPhone 17 “Supercycle” Buzz – Will the Rally Last?

Apple stock closed at a record $262.24 on Oct. 20, up nearly 4% after iPhone 17 sales jumped 14% over last year’s launch in the U.S. and China. Loop Capital and Evercore ISI raised ratings and targets, but Jefferies downgraded the stock, citing high expectations. Apple neared a $4 trillion valuation. Earnings are due Oct. 30, with analysts expecting $101 billion in revenue.
20 October 2025
··
Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics shares jumped 17% to $30.35 on Oct. 20, 2025, marking their highest level since early 2024. The rally followed bullish technical signals and positive clinical updates for its gene-editing therapies. Analysts at Jefferies and H.C. Wainwright reiterated Buy ratings, with price targets up to $80. Beam ended Q2 with $1.2 billion in cash, enough to fund operations into 2028.
20 October 2025
·····
Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity shares jumped over 40% Monday to a record near $80 after Phase 3 trial data showed its drug gedatolisib cut risk of progression or death by 76% in advanced HR+/HER2- breast cancer. The company confirmed full enrollment of the PIK3CA-mutant cohort, with final results expected by mid-2026. Needham raised its price target to $95. Celcuity’s market cap topped $2.2 billion.
20 October 2025
··
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce Stock Surges After $60B AI Bombshell – Here’s What’s Next (Oct 20, 2025)

Salesforce shares surged nearly 7% to $253 on Thursday, Oct. 16, 2025, after unveiling new long-term revenue targets and AI plans at Dreamforce. The stock eased to close Friday near $243 and traded in the mid-$240s Monday. Year-to-date, CRM is down about 27–28%. Wall Street analysts remain mostly bullish, with average price targets around $330.
20 October 2025
····
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Stock Rockets on Samsung Mega-Deal and Cancer Test Breakthrough

GRAIL shares surged 14% to a record $85.35 on Oct. 16 after Samsung agreed to invest $110 million and partner on cancer test rollout in Asia. New trial data showed Galleri’s blood test boosted early cancer detection seven-fold in a 25,000-patient study. GRAIL secured $325 million in fresh funding, extending its cash runway into 2030. Analysts remain cautious, with a consensus Hold rating and a $57 price target.
20 October 2025
···
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Gold Rush: D-Wave (QBTS) Stock Skyrockets on Quantum Breakthroughs & Hype – What’s Next?

D-Wave Quantum shares surged over 3,000% in the past year, hitting a record $46.75 before retreating to the mid-$30s. The company announced it will redeem all public warrants by Nov. 19, triggering a 4% pre-market gain. Last week, D-Wave signed an €10 million deal to deploy its quantum computer in Europe. Roth Capital raised its price target to $50 after the news.
20 October 2025
···
1 … 1,640 1,641 1,642 1,643 1,644 … 1,847

Stock Market Today

  • Janus and Tecnoglass Shares Surge on Geopolitical Ceasefire Hopes
    April 10, 2026, 2:54 AM EDT. Shares of Janus and Tecnoglass jumped following news that Israel and Lebanon may begin direct talks, supporting a fragile U.S.-Iran ceasefire. The S&P 500 moved into positive territory as investors saw the easing of Middle East tensions as a sign that the worst phase of the conflict may be over. Lower geopolitical risks help stabilize inflation expectations and mortgage rates, benefiting sectors like homebuilding. Tecnoglass's stock, known for volatility with 14 moves over 5% last year, gained on the news but remains 48.7% below its 52-week high. Despite a 12.8% drop year-to-date, a $1,000 investment in Tecnoglass five years ago is now worth over $3,450.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 2:57 AM EDT Janus and Tecnoglass Shares Surge on Geopolitical Ceasefire Hopes April 10, 2026, 2:54 AM EDT. Shares of Janus and Tecnoglass jumped following news that Israel and Lebanon may begin direct talks, supporting a fragile U.S.-Iran ceasefire. The S&P 500 moved into positive territory as investors saw the easing of Middle East tensions as a sign that the worst phase of the conflict may be over. Lower geopolitical risks help stabilize **inflation expectations** and mortgage rates, benefiting sectors like homebuilding. Tecnoglass's stock, known for volatility with
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Go toTop